A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway

Author： Nolan Ryan   Bree Andrea   Zutshi Anup  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.40, Iss.5, 2013-10, pp. : 609-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 692-699

Bentham Science Publishers

Access to resources Recommend Favorite

The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 7, 2015-01 ,pp. : 838-854

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense modulation of Toll-like receptor 4 expression

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1887-1889

Informa Healthcare

Access to resources Recommend Favorite

Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion

By  

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the toll-like receptor 7 pathway in asthma: a potential immunomodulatory approach?

By Antoniu Sabina A  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 667-669

Informa Healthcare

Access to resources Recommend Favorite